Table 4. Individual components of the global assessment of inflammation at day 15 (intent-to-treat population).

Individual components of global assessment of inflammation	Patients with grade 0, n (%)
	Difluprednate 0.05% (n=39)	Prednisolone acetate 1% (n=40)
Anterior chamber cell	30 (78.9)	31 (77.5)
Anterior chamber flare	29 (74.4)	28 (70.0)
Corneal clarity	37 (94.9)	36 (90.0)
Conjunctival injection	35 (89.7)	37 (92.5)
Ciliary/limbal injection	39 (100.0)	40 (100.0)
Chemosis	39 (100.0)	39 (97.5)
Hypopyon	39 (100.0)	40 (100.0)
Vitritis	39 (100.0)	39 (97.5)
Wound integrity	39 (100.0)	40 (100.0)
Photophobia	38 (97.4)	38 (95.0)
Lacrimation	39 (100.0)	38 (95.0)